FDA Approves Unknown Drug — ACTAVIS LABS FL INC

On June 16, 2004, ACTAVIS LABS FL INC received FDA approval for ANDA076172, allowing the company to launch a generic drug without a specific brand or substance name listed. This regulatory clearance enables ACTAVIS to capture market share in an unbranded pharmaceutical segment, driving incremental revenue despite the absence of a brand identifier.